KDM2B-IN-3

• Description :

  KDM2B-IN-3 is a histone demethylase KDM2B inhibitor extracted from patent WO2016112284A1, compound 183c. KDM2B-IN-3 can be used for the research of cancer[1].

• CAS Number :

  [1966933-87-8]

• UNSPSC :

  12352005

• Target :

  Histone Demethylase

• Type :

  Reference compound

• Related Pathways :

  Epigenetics

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/kdm2b-in-3.html

• Solubility :

  10 mM in DMSO

• Smiles :

  N#CCC1=C(OC)C=CC2=C1C=CC(C([C@@H]3[C@H](CCN(C4CCC4)C3)CC)=O)=C2

• Molecular Formula :

  C25H30N2O2

• Molecular Weight :

  390.52

• References & Citations :

  [1]Albrecht BK, et, al. (piperidin-3-yl) (naphthalen-2-yl) methanone derivatives and related compounds as inhibitors of the histone demethylase kdm2b for the treatment of cancer. WO2016112284A1.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• Isoform :

  KDM2